Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
MRK

Merck

$75.85

-0.02 (-0.03%)

04:21
01/23/19
01/23
04:21
01/23/19
04:21
Downgrade
Merck rating change  »

Merck downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 01

    Feb

  • 16

    Feb

  • 11

    Apr

  • 18

    May

Yesterday
ALXN

Alexion

$113.31

-3.66 (-3.13%)

, AMGN

Amgen

$201.74

-2.18 (-1.07%)

10:24
01/22/19
01/22
10:24
01/22/19
10:24
On The Fly
Alexion slips on Soliris EU patent setback, though analysts see limited impact »

Shares of Alexion…

ALXN

Alexion

$113.31

-3.66 (-3.13%)

AMGN

Amgen

$201.74

-2.18 (-1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 04

    Feb

  • 18

    Feb

ALXN

Alexion

$116.97

2.32 (2.02%)

, AMGN

Amgen

$203.92

1.98 (0.98%)

09:39
01/22/19
01/22
09:39
01/22/19
09:39
Recommendations
Alexion, Amgen analyst commentary at Piper Jaffray »

Piper says Alexion should…

ALXN

Alexion

$116.97

2.32 (2.02%)

AMGN

Amgen

$203.92

1.98 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 04

    Feb

  • 18

    Feb

AMGN

Amgen

$203.92

1.98 (0.98%)

09:04
01/22/19
01/22
09:04
01/22/19
09:04
Hot Stocks
Amgen: EC approves expanded indication for BLINCYTO monotherapy »

Amgen announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

Friday
MRK

Merck

$75.68

0.08 (0.11%)

, SSNLF

Samsung

$0.00

(0.00%)

16:04
01/18/19
01/18
16:04
01/18/19
16:04
Hot Stocks
FDA approves Samsung Bioepis-Merck biosimilar to Roche's Herceptrin »

The FDA announced that it…

MRK

Merck

$75.68

0.08 (0.11%)

SSNLF

Samsung

$0.00

(0.00%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 28

    Jan

  • 01

    Feb

  • 16

    Feb

  • 18

    Mar

  • 11

    Apr

  • 18

    May

AZN

AstraZeneca

$36.56

0.28 (0.77%)

14:30
01/18/19
01/18
14:30
01/18/19
14:30
Options
Aggressive call buy in AstraZeneca »

Aggressive call buy in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANTM

Anthem

$264.48

2.6 (0.99%)

, CI

Cigna

$195.52

1.05 (0.54%)

11:00
01/18/19
01/18
11:00
01/18/19
11:00
Conference/Events
Morgan Stanley healthcare/pharma analysts hold analyst/industry conference call »

Healthcare Services &…

ANTM

Anthem

$264.48

2.6 (0.99%)

CI

Cigna

$195.52

1.05 (0.54%)

HUM

Humana

$295.55

4.66 (1.60%)

MOH

Molina Healthcare

$137.34

1.92 (1.42%)

UNH

UnitedHealth

$261.78

2.06 (0.79%)

MRK

Merck

$75.73

0.13 (0.17%)

PFE

Pfizer

$42.42

-0.04 (-0.09%)

INSM

Insmed

$24.52

-0.15 (-0.61%)

PTLA

Portola Pharmaceuticals

$26.25

0.63 (2.46%)

GILD

Gilead

$68.99

0.34 (0.50%)

TMO

Thermo Fisher

$239.79

1.62 (0.68%)

QGEN

Qiagen

$36.89

0.25 (0.68%)

ABT

Abbott

$71.62

1.09 (1.55%)

PODD

Insulet

$74.87

0.06 (0.08%)

TFX

Teleflex

$257.01

2.42 (0.95%)

ZBH

Zimmer Biomet

$105.00

-1.16 (-1.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 27

    Jan

  • 28

    Jan

  • 29

    Jan

  • 30

    Jan

  • 30

    Jan

  • 30

    Jan

  • 01

    Feb

  • 01

    Feb

  • 06

    Feb

  • 12

    Feb

  • 16

    Feb

  • 19

    Feb

  • 11

    Apr

  • 18

    May

  • 28

    May

LLY

Eli Lilly

$119.20

2.46 (2.11%)

09:23
01/18/19
01/18
09:23
01/18/19
09:23
Recommendations
Eli Lilly analyst commentary at JPMorgan »

Eli Lilly trial miss a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 18

    May

BMY

Bristol-Myers

$49.60

0.47 (0.96%)

, GSK

GlaxoSmithKline

$38.98

0.58 (1.51%)

08:31
01/18/19
01/18
08:31
01/18/19
08:31
Periodicals
Pharmas hike prices on some older medictions amid recalls, shortages, WSJ says »

Amid supply shortages and…

BMY

Bristol-Myers

$49.60

0.47 (0.96%)

GSK

GlaxoSmithKline

$38.98

0.58 (1.51%)

PFE

Pfizer

$42.46

0.37 (0.88%)

JNJ

Johnson & Johnson

$129.11

1.11 (0.87%)

AZN

AstraZeneca

$36.28

0.49 (1.37%)

MRK

Merck

$75.60

1 (1.34%)

LLY

Eli Lilly

$119.20

2.46 (2.11%)

NVS

Novartis

$88.56

0.59 (0.67%)

SNY

Sanofi

$42.04

-0.15 (-0.36%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 24

    Jan

  • 27

    Jan

  • 28

    Jan

  • 28

    Jan

  • 29

    Jan

  • 01

    Feb

  • 16

    Feb

  • 18

    Feb

  • 28

    Feb

  • 11

    Mar

  • 18

    Mar

  • 22

    Mar

  • 11

    Apr

  • 28

    Apr

  • 18

    May

  • 20

    May

AIMT

Aimmune

$22.64

-0.82 (-3.50%)

, LLY

Eli Lilly

$119.20

2.46 (2.11%)

08:08
01/18/19
01/18
08:08
01/18/19
08:08
Hot Stocks
Aimmune appoints Andrew Oxtoby as Chief Commercial Officer »

Aimmune Therapeutics…

AIMT

Aimmune

$22.64

-0.82 (-3.50%)

LLY

Eli Lilly

$119.20

2.46 (2.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 18

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.